For Myelofibrosis Patients: The Latest on Promising Treatments from Top Specialist | Dr. Ruben Mesa

Описание: Description:
Myelofibrosis (MF) is one of the more rare forms of myeloproliferative neoplasms (MPNs) but also the most common one to turn into acute myeloid leukemia (AML). That’s why so much research is pouring into more treatment options for MF, with clinical trials trying to test new drugs, as well as combinations.
Historically speaking, MF treatments often become an option for patients of other MPNs, like polycthemia vera (PV) and essential thrombocythemia (ET).
To help sort through what patients need to know, we sit down with top MPNs specialist, Dr. Ruben Mesa.

Featuring:
Dr. Ruben Mesa
Executive Director of Mays Cancer Center
Director of UT Health San Antonio MD Anderson Cancer Center
Myeloproliferative Neoplasms (MPNs) Specialist

In this Series: Dr. Mesa covers the latest updates focused on MPNs following the biggest blood cancer/disease conference (ASH) held at the end of 2021 that looked forward to emerging treatments studied in 2022 and beyond.

Full story & transcript → Updated Soon at www.ThePatientStory.com

Videos:
1) Essential Thrombocythemia Updates for Patients and Caregivers (2022):    • Essential Thrombocythemia: What Patients S...  
2) Polycythemia Vera: Latest Updates for Patients & Caregivers in 2022:    • Polycythemia Vera: Latest Updates for Pati...  

The interview has only been edited for clarity.

Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story

Contents of this video:
00:00 - intro
00:17 - Biggest updates on myelofibrosis and treatments
07:03 - Deciding if patients should start with single drug or combination
08:35 - What are the known side effects of pelebresib?
09:46 - Pacritinib's impact on patients with more severe low platelets
10:47 - Overall look at MPN treatments in 2022
12:34 - Expected update for why MF progresses into AML (acute myeloid leukemia)
13:54 - The goal of curing patients with MPNs
15:20 - The importance of clinical trials for patients
16:53 -Community oncologists working with MPN specialists

____________________________

#ThePatientStory #bloodcancer #blooddisease #hematology #oncology #MPN #myeloproliferativeneoplasms #essentialthrombocythemia #polycythemiavera #clinicaltrials #relapsedrefractory #Patientcare #cancertreatment #Cartcelltherapy